Tag Archives: PulseSight Therapeutics

BIOTECH

Body Vision Medical Closes New Funding Round to Accelerate Global Expansion of AI-Powered Intraoperative Imaging

Body Vision Medical, a global leader in AI-powered intraoperative imaging, has closed a new round...

Read more

R&D SERVICES/CRO

Inside the NHS Hospital Trialling Psychedelics to Treat Depression

Since being diagnosed with depression in 1995, Leonie Schneider has been prescribed antidepressants for over...

Read more

BIOTECH

EBT Medical and NinaMED Announce US$13.75M Financing to Advance Licensed NiNA System® for Overactive Bladder

US$13.75M financing completed to accelerate clinical pathway and global commercialisation Establishment of NinaMED Pty Ltd,...

Read more

BIOTECH

Hope for Dry AMD: Novel Gene Therapy Completes First Human Safety Trial

Paris, France – April 23, 2026 – In a significant development for the millions suffering...

Read more

BIOTECH

Dosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)

Paris, France, January 22, 2026 – PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing...

Read more